Hexadentate tris(3,4-hydroxypyridinone) ligands (THP) complex Fe3+ at very low iron concentrations and their high affinities for oxophilic trivalent metal ions have led to their development for new applications as bifunctional chelators for the radiometal gallium-68 (68Ga). THP-peptide bioconjugates rapidly and quantitatively complex 68Ga at room temperature, neutral pH, and micromolar ligand concentrations, making them amenable to kit-based radiosynthesis of 68Ga PET radiopharmaceuticals. With the aim to produce an N-hydroxysuccinimide-(NHS)-THP reagent for kit-based 68Ga-labeling and PET imaging, THP-derivatives were designed and synthesized to exploit the advantages of NHS chemistry for coupling with peptides, proteins, and antibodies. The more stable five-carbon atoms linker product was selected for a proof-of-concept conjugation and radiolabeling study with an anti-programmed death ligand 1 (PD-L1) camelid single domain antibody (sdAb) under mild conditions and further evaluated for site-specific amide bond formation with a synthesized glucagon-like peptide-1 (GLP-1) targeting peptide using solid-phase synthesis. The obtained THP-GLP-1 conjugate was tested for its 68Ga chelating ability, demonstrating to be a promising candidate for the detection and monitoring of GLP-1 aberrant malignancies. The obtained sdAb-THP conjugate was radiolabeled with 68Ga under mild conditions, providing sufficient labeling yields after 5 min, demonstrating that the novel NHS-THP bifunctional chelator can be widely used to easily conjugate the THP moiety to different targeting molecules (e.g., antibodies, anticalins, or peptides) under mild conditions, paving the way to the synthesis of different imaging probes with all the advantages of THP radiochemistry.
Radiolabelled lipophilic cations could potentially be used to non-invasively image mitochondrial dysfunction in cardiovascular disease, building on their current role as perfusion imaging agents. We have synthesised and radiolabelled two series of DO2A-based radiotracers, with bistriarylphosphonium- and bisaryl-functionalisation respectively, with gallium-68 to form lipophilic cations. Both sets of tracers radiolabel with over 90% RCP, although the tracers form kinetic/thermodynamic pairs of species upon gallium chelation that can be visualised and separated by radioHPLC. Log D7.4 values above −0.3 are observed for the most lipophilic examples of each series of radiotracers. Both tracers show significant preferential uptake in healthy cardiac tissue over cardiac tissue depolarised by CCCP.
Radiolabelled bisphosphonates (BPs) and [18F]NaF (18F-fluoride) are the two types of radiotracers available to image calcium mineral (e.g. bone), yet only [18F]NaF has been widely explored for the non-invasive molecular imaging of extraosseous calcification (EC) using positron emission tomography (PET) imaging. These two radiotracers bind calcium mineral deposits via different mechanisms, with BPs chelating to calcium ions and thus being non-selective, and [18F]NaF being selective for hydroxyapatite (HAp) which is the main component of bone mineral. Considering that the composition of EC has been reported to include a diverse range of non-HAp calcium minerals, we hypothesised that BPs may be more sensitive for imaging EC due to their ability to bind to both HAp and non-HAp deposits. We report a comparison between the 68Ga-labelled BP tracer [68Ga]Ga-THP-Pam and [18F]NaF for PET imaging in a rat model of EC that develops macro- and microcalcifications in several organs. Macrocalcifications were identified using preclinical computed tomography (CT) and microcalcifications were identified using µCT-based 3D X-ray histology (XRH) on isolated organs ex vivo. The morphological and mineral analysis of individual calcified deposits was performed using scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX). PET imaging and ex vivo analysis results demonstrated that while both radiotracers behave similarly for bone imaging, the BP-based radiotracer [68Ga]Ga-THP-Pam was able to detect EC more sensitively in several organs in which the mineral composition departs from that of HAp. Our results strongly suggest that BP-based PET radiotracers such as [68Ga]Ga-THP-Pam may have a particular advantage for the sensitive imaging and early detection of EC by being able to detect a wider array of relevant calcium minerals in vivo than [18F]NaF, and should be evaluated clinically for this purpose.
Pretargeted PET imaging has emerged as a leading strategy for tracking long-circulating agents such as antibodies and nanoparticle-drug delivery systems with short-lived isotopes. Compared to the conventional direct radiolabeling approach, pretargeting benefits from high sensitivity and spatial resolution of PET while minimizing radiation doses and nonspecific accumulation of radioactivity. In addition, it allows for long-term in vivo tracking possibilities. However, a pretargeting approach that can utilize readily available radionuclides as obtained from the generator/cyclotron without the need of complex radiochemical synthesis is highly desirable. Here, we report a metal chelation pretargeting system based on the 68Ga chelator tris(hydroxypyridinone) (THP). THP can be radiolabeled at low concentrations with as-obtained generator-produced radionuclide gallium-68 (t1/2 = 68 min) at room temperature and physiological conditions with high efficiency. The bifunctional chelator THP-NCS was conjugated to either PEGylated liposomes or a bone-targeting aminobisphosphonate (pamidronate) to examine the metal chelation pretargeted imaging system in both long-circulating nanomedicines and short-circulating small molecules, respectively. In vivo imaging experiments were performed in healthy BalB/c mice at multiple time points. For liposomal pretargeting, the fraction of liposomes circulating in the blood was efficiently radiolabeled in vivo, but limited in vivo radiolabeling was observed for liposomes that had accumulated in the liver and spleen. The pretargeting of the small-molecule, bone-targeting bisphosphonate THP-Pam showed moderate in vivo radiolabeling in bones. Overall, based on this study, the metal chelation method appears to allow easy pretargeting for agents present in the blood and bones but with limited success in other organs.
The coordination of three tri- and tetra-aza macrocycles carrying neutral phosphine oxide pendant arms, towards divalent late 3d metal ions reveals a strong dependency on the overall ligand denticity and the macrocyclic ring size.